All posts by imreal

DIA Dental Implant Center Specialists Resolve Bone Loss Challenges, Placing the First Neodent® Zygoma GM™ Implant in the U.S.


Drs. Dan Holtzclaw and Juan Gonzalez, Dental Implant Specialists in Austin, TX

Drs. Dan Holtzclaw and Juan Gonzalez Place First Neodent® GM™ Zygomatic Implant in the U.S.

The type of precision needed to place a zygomatic implant can only be accomplished by a highly experienced dental implant surgeon.

Dr. Dan Holtzclaw, founder of the DIA Dental Implant Center, and fellow implant surgeon Dr. Juan Gonzalez place the first Neodent® Grand Morse® zygomatic implant in the United States. Patients with severe bone loss are often ineligible for dental implant treatment. However, with Neodent’s revolutionary zygomatic implant, the doctors at DIA Dental Implant Center can provide a permanent tooth replacement solution for those suffering from severe bone loss in Austin, TX.

Unlike traditional dental implants, which are placed along the jawbone ridge, a zygomatic implant anchors into an area in the jawbone near the zygoma bone. This bone, although more difficult to reach, is denser bone. Precisely anchoring dental implants into this specialized bone not only qualifies most patients for immediate load implants, but it also eliminates the need for time-consuming and extensive bone grafting treatment.

The Straumann Group, a world leader in implantology, created the Grand Morse zygomatic implant utilizing their Cone Morse technology. The deep Cone Morse connection provides a high resistance, incredible stability, and enhanced protection against bacteria. With this level of detail, Neodent zygomatic implants provide exceptional long-term mechanical stability.

The type of precision needed to place a zygomatic implant can only be accomplished by a highly experienced dental implant surgeon. The implant specialist at DIA Dental Implant Center has a level of expertise that is respected internationally among the dental implant industry. Drs. Holtzclaw and Gonzalez have both published multiple articles in peer-reviewed dental journals that document the successful use of zygomatic implants in severe bone loss cases. They are frequently invited to lecture on the advancements in full mouth dental implants at major dental conferences throughout the world.

DIA Dental Implant Center is among the few implant centers in the United States to offer zygomatic implants to help patients with bone loss. Featuring a team of oral surgeons, prosthodontists, and experienced dental technicians, as well as an in-house lab with the state-of-the-art Zirkonzahn™ technology, any patients looking for a permanent tooth replacement solution find the greatest eligibility and the highest quality of care at DIA Dental Implant Center. Even patients with bone loss are often able to experience the benefits of full mouth dental implants in just one visit, with no need for an extensive bone grafting procedure.

Those suffering from tooth and bone loss in Austin, TX who are looking for a permanent tooth replacement solution can connect with DIA Dental Implant Center for a zygomatic implant consultation. To schedule an appointment, visit http://www.diadentalimplants.com or call the office at 512-375-0050.

About the Practice

DIA Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world’s leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIArch™ implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With an in-house laboratory utilizing world-class Zirkonzahn™ technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, DIA Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices. To learn more about the DIA Dental Implant Center advantage visit http://www.diadentalimplants.com or call 512-375-0050.

Share article on social media or email:

Dr. Lee Neubert Joins Physician Partners of America


Lee Neubert, D.O.

Lee Neubert, D.O.

“I believe in treating every person as an individual with dignity and respect.” –Lee Neubert, D.O.

Physician Partners of America welcomes Lee Neubert, D.O. to its Melbourne practice at 7000 Spyglass Ct. Dr. Neubert is a dual board-certified specialist in both anesthesiology and pain management through the American Board of Anesthesiology.

Dr. Neubert grew up in Pittsburgh, PA. He did his undergraduate studies at Allegheny College, graduating with a B.S. in Biology. He then went on to receive his medical degree from the Philadelphia College of Osteopathic Medicine.

After completing medical school, he completed his internship at Delaware County Memorial Hospital in Drexel Hill, PA. He fulfilled his residency training at Hahnemann University Hospital in Philadelphia, where he was elected chief resident by his peers and instructors. Upon graduation in 2014, he was accepted into a pain management fellowship at Allegheny General Hospital – Western Pennsylvania Hospital in affiliation with Drexel University College of Medicine and Temple University College of Medicine.

Dr. Neubert specializes in interventional techniques to treat various forms of chronic pain including image guided joint injections, epidural steroid injections, radiofrequency ablations, spinal cord stimulators, percutaneous vertebral augmentations and intrathecal pain medication delivery systems.

“I believe in treating every person as an individual with dignity and respect.” –Lee Neubert, D.O.

He believes chronic pain management can be complicated and is treated best with a multidisciplinary approach. He stresses interventional therapies as alternatives to masking symptoms to treat the source of the pain.

Dr. Neubert has been published in both medical journals and textbooks. He is also certified in advanced cardiovascular life support and basic life support.

Patients can make appointments, including same-day visits, with Dr. Neubert starting January 2, 2019 at the office, located at 7000 Spyglass Court Suite 310. Office hours are 8 a.m. to 5 p.m.

About PPOA:

Physician Partners of America (PPOA) is a national healthcare organization focused on strengthening the doctor-patient relationship, improving patient outcomes and leading the fight against the opioid crisis. Founded in 2013 and headquartered in Tampa, Fla., PPOA and its affiliates share a common vision of ensuring the wellbeing of patients through interventional and minimally invasive treatments, pain management, and laser spine procedures. Its model allows its physician partners to focus on caring for patients in the face of increasingly complex administrative requirements. For more information about Physician Partners of America, visit http://www.physicianpartnersofamerica.com

Share article on social media or email:

GGI’s Innovation Leadership Mini-Series Videos Are Now Available for Corporate License: Breakthrough Innovation, Product Design, Smart R&D Spending, Metrics


10 Breakthrough Innovation Techniques

10 Breakthrough Innovation Techniques

Professional, well structured, well thought out. Thought provoking and content rich. Plenty of take-aways. — R&D Director, Millipore

In an economic uptick, there are more resources to deploy. Spending goes up. More things are possible. Alternatives increase. How do you choose wisely?

Out-innovating the competition, smart R&D decisions and spending, and distinct value-enhancing product design and packaging are three topics that get a lot of time in the board room and offices of corporate leaders. We address each of these subjects with a three-hour Mini-Series consisting of three one-hour programs.

The Innovation Performance 10-9-8 Series

10 Techniques That Achieve Breakthrough Innovation: This program focuses on ten differentiable techniques that have evolved since Clayton Christensen first coined “Disruptive Innovation” in the 1990s. These ten techniques are all disruptive in some way across the spectrum of disruption: Breakthrough, Disruptive, Radical, Transformational, New-To-The-World, New-To-The-Industry, and Next Generation.

9 KPIs That Capture Innovation Performance: This program focuses on nine Key Performance Indicators (KPIs) that together capture the lion’s share of overall innovation performance. These nine KPIs span investment levels, innovation levels, execution ability, productivity, and overall business performance.

8 Practices That Boost Corporate Innovation: This program focuses on eight processes, tools, and techniques that are known to increase innovation creativity and execution, and/or the value of investments in innovation, in corporations. Some are strategic and soft in nature, such as communication and messaging. Some are tactical, such as combining products and IP in business plans. Others are process-oriented and spur raw innovation or the early detection of errors.

The R&D Spending Performance 8-8-8 Series

8 Conditions That Impact R&D Spending Results: This program focuses on factors that will negatively impact spending and spending performance. Some of them are controllable, some are not. We discuss eight conditions ranging from spending decisions in boom and bust periods, to overspending and underspending, to the impacts of variable spending and negative events on output and productivity, that lessen output and outcomes.

8 Metrics That Quantify R&D Spending Performance: This program focuses on key performance indicators [KPIs] that have R&D spending in their calculation. The metrics range from corporate metrics that are either reported to Wall Street or used by analysts and CFOs, to measures that help to divvy-up funds across business units of different purposes and performance levels, to measures that improve the ranking of investments, to measures that can be used to modulate overspending or underspending for corporate and industry considerations.

8 Actions That Increase R&D Spending Output: This program focuses on factors that will positively influence spending and spending performance. All of them are within your control. Does your company have its arms around these? We describe eight actions ranging from good CXO behaviors, to data sciences and digital posturing, to timing new product announcements and actively competing for awards, that increase output and outcomes.

The Product Design Value 7-6-7 Plus Series

7 Ways To Create Value With Product Design: This program focuses on opportunities to design-in capabilities that will enhance the appeal and increase the value of products from their point of purchase throughout the product’s life cycle. We will discuss seven different opportunities, and quantify the size of the economic opportunity for each. The least opportunity represents a 20% increase in revenues unto itself. The several large opportunities represent upwards from 200% increases in revenue and profit from the same design effort. The Plus in this 7-6-7 Series program will touch on how miniaturization of design, next generation motors, and a couple more topics will also begin to influence product design.

6 Ways To Reap Value From Product Design: This program focuses on opportunities to increase the value of products, portfolios, and brands that have been robustly designed, or are well along to that goal. We will discuss six different opportunities, and quantify the size of the economic opportunity for each. These opportunities all have double-digit potential to increase revenues and profits, and single digit for market cap. In some cases, incremental monies will be needed to realize the augmentation potential of the design or design-leverage ability. The Plus in this 7-6-7 Series program will cull-out selected awards and recognitions for good product design, as distinguished from the multitude of award and recognition program categories existing today.

7 Measures To Value Product Design: The third program focuses on measures that characterize or quantify good design in the eyes of customers and users. While some measures also have utility for internal purposes such as product quality, reliability, and cost, this program centers on how customers, users, markets, and the investor community regard the products. We discuss seven different KPIs that range from codifying the quality and robustness of ID and UX designs, to metrics that gauge pricing gross margins and potential market value, to indexes that provide for cross-market comparisons and market cap premiums. The Plus in this 7-6-7 Series program will briefly touch on several other metrics relevant to good product design including customer satisfaction, completion rates, NPS, and others.

Program Leader

Founded in 1986, Bradford Goldense’s company has consulted to over 200 medium and large companies. Some 500 companies have participated in GGI’s educational events. Since 1998 the company has performed primary and secondary research on R&D, product development, innovation, and metrics. For twenty years, Brad also taught in the weekend executive Masters in Engineering Management program at The Gordon Institute at Tufts University. Mr. Goldense is a cited author in over three-hundred publications, many of which may be found in Google Scholar and ResearchGate.

Licensing

Corporate Licenses are now a value at three times the single-user price. Positive actions on any of the 10-9-8, 8-8-8, and 7-6-7 group of topics can make or save tens of thousands of dollars apiece, even if only implemented once. A short license statement accompanies each video transmittal. There is nothing to sign.

Share article on social media or email:

Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline


The 505(b)(2) product pipeline offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients.

We are a full-service pharmaceutical R&D company aiming to be your go-to development partner

Vici has completed first round of communication with FDA and is currently working on scaling up the manufacturing process in anticipation of entering the registration phase of the project.

Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients. The products concepts were identified in collaboration with doctors and managed care professionals and developed at Vici’s R&D facility in Maryland. Vici has completed first round of communication with FDA and is currently working on scaling up the manufacturing process in anticipation of entering the registration phase of the project. Simultaneously Vici is in talks with its commercialization partners to ensure the doctors and patients have full access to these products that will significantly help improve patient outcomes.

About Vici Health Sciences LLC

Vici Health Sciences (Vici) is a U.S. based pharmaceutical research and development company. Vici is focused on specialty branded and generic pharmaceutical product development and commercialization. Vici’s goal is to improve clinical outcomes, enhance access, and reduce costs for patients and healthcare providers.

Share article on social media or email:

View article via:


Pdf

Print

Finding a Needle in a Haystack for FDA Inspections Webinar, Jan. 10, 2020


WCG FDANews Logo

WCG FDANews Logo

Organizing Data and Document Archives:

Finding a Needle in a Haystack for FDA Inspections

An FDAnews Webinar

Jan. 10, 2020 • 1:30 p.m. – 3:00 p.m. EST

https://www.fdanews.com/organizingdatadocarchives

Six words not to utter on FDA inspection day:

‘Now, where is that darn document?’

Paper documents unscanned. Naming conventions that don’t make sense. Emails as GXP documentation. Poor communication with the vendors that generate the data. Non-functional (or non-existent) SOPs. Documents missing altogether. Yes, data retrieval is in a sorry state at far too many drug, device, biologics and diagnostics companies.

But the next inspection day need not become scavenger hunt day. Create effective new SOPs for electronic document management or improve existing ones. It’s easy — when one knows how.

FDAnews has invited leading GXP (GCP/GLP/GMP) consultant, David Chesney, to help attendees get control of data. In 90 fast-paced minutes one will learn the basics of developing best practices and SOPs that turn inspection nightmares into routine management tasks. Here’s just a taste of what attendees will discover:


  • The legal basis of FDA records access authority, including what FDA can’t access
  • Types of documents commonly requested during inspections
  • Problems and pitfalls to avoid
  • The Top 10 questions to ask about the archival process
  • What to do when documents are not in the general archives
  • The perils of emails as GXP documentation — and how to avoid them
  • If source data is electronic, how to provide access to the regulatory authority
  • True copies versus originals — what is deemed acceptable under GXP regulations?
  • The impact of the shift to real time electronic review of documents during inspections

Don’t go searching for the needle in a haystack on inspection day.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Organizing Data and Document Archives:

Finding a Needle in a Haystack for FDA Inspections

An FDAnews Webinar

Jan. 10, 2020 • 1:30 p.m. – 3:00 p.m. EST

https://www.fdanews.com/organizingdatadocarchives

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/organizingdatadocarchives

By phone: 888-838-5578 or 703-538-7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Leak Detection Associates Celebrates Major 2019 Milestones


As 2019 comes to a close, we are proud of our new facility and fresh product line which a platform for continued success in providing solutions for our clients worldwide

Leak Detection Associates (LDA), the world’s premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited to celebrate the completion of its first calendar year under new management. Following acquisition by CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization plan was implemented by CEO Brian Mulhall, intended expand and improve product and service offerings to a global market. Multiple major milestones were achieved over the course of 2019, including opening a new company headquarters, strategic partnerships for global distribution and support, new product offerings including the Agilent-based SIMS 1915+ and low temperature (-80°C) testing systems, and the launch of newly developed Part-11 compliant SIMS software.

“Entering 2019, we outlined ambitious goals that, if accomplished, would reaffirm LDA’s position as the premier manufacturer of helium leak test instruments specifically tailored to the regulated life sciences industries” commented Alan Weiss, Chief Financial Officer of LDA. “As 2019 comes to a close, we are proud of our new facility and fresh product line which a platform for continued success in providing solutions for our clients worldwide.”

While helium leak detection has a longstanding history of use in pharmaceutical packaging operations, with ASTM F2391-05 being written by LDA founder Dr. Darrell Morrow, recent industry guidelines such as USP 1207 and the proposed revision to EU Annex 1 continue to drive adoption of more sensitive and deterministic leak tests worldwide. To better connect with this market, LDA launched a redesigned website in 2019 and has made a commitment to participating in industry events, such as Interphex and Parenteral Drug Association (PDA) Workshops on CCIT. To better cater to LDA’s client base with global site networks, newly established strategic partnerships were forged, including an agreement with IPP for instrument distribution and support across the UK and Ireland.

Critical to the 2020 product line, Director of Engineering Jeff Morrow-Lucas and his team created two new hardware offerings in 2019; notably the SIMS 1915+ Helium Leak Detection System packaged with LDA’s newly released, Part-11 compliant SIMS software. Incorporating Agilent Technologies components, the new system, completely redesigned, marks improvements in instrument performance, intuitive operation, and access to Agilent’s global maintenance and service network, while the newly developed SIMS software ensures data integrity. In addition, the newly released LT80 add-on system enables testing of pharmaceutical package systems at temperatures as low as -80°C, critical for many biologics, cell and gene therapies, which require storage or shipment at aggressive temperatures that can cause leakage.

As clients have come to expect, each new SIMS 1915+ will be customized to client’s specific testing needs, whether testing vials, blister cards, cartridges, or pre-filled syringes. Each SIMS 1915+ can be complimented with Leak Detection Associates’ robust and ever-expanding catalog of accessories, service, and contract offerings to provide end-to-end leak testing solutions.

About Leak Detection Associates, LLC

For over 20 years, Leak Detection Associates has been the premier manufacturer of custom helium leak detection instruments for the pharmaceutical, biotechnology, medical device and food packaging industries. LDA’s well-established technology has been incorporated into ASTM and compendia guidance documents. This robust industry experience, combined with the advanced capabilities of its newest model the SIMS 1915+ helium leak detection unit, provides companies with tools to quantitatively evaluate leakage, improve the package development cycle, establish manufacturing controls, and ultimately reduce risk to the product and consumer throughout the lifecycle.

Share article on social media or email:

The Dinosaurs Got By without Dental Hygiene but People Can’t says A-Z Dental Care


Assuming you’re not a dinosaur and are a human being, regular dental visits are essential.

Prevention should be the goal for all patients and stresses healthy choices along with routine checkups.

A November 30th article on MSN reports that a known species of carnivorous dinosaur, Majungasaurus, is believed to have been capable of naturally replacing its teeth in as little as two months. This rate, more akin to sharks than the Majungasaurus’ peer species of dinosaurs, far outpaced any other known rate of tooth replacement in dinosaurs and is hypothesized to be due to the massive carnivore’s propensity to gnaw on bones. West Covina-based dental center A-Z Dental Care says that while dinosaurs may have been able to replace their teeth more than once, humans only get a baby set and a permanent adult set: once the latter set is gone, there is no natural replacement and that means good dental hygiene is a must.

A-Z Dental Care notes that unlike the Majungasaurus and so many other animals, people do not usually gnaw on bones, which easily grind down teeth. However, the dental center points out that plenty of its patients possess habits that are not always the most oral-health friendly. For example, the office mentions a variety of foods and beverages such as coffee, tea, candy and sweets in both liquid and solid forms that can wreak havoc on a patient’s teeth if consumed regularly with minimal or negligent dental hygiene habits. The center notes that the risk for tooth maladies related to acidic food and sweets does decrease when individuals exhibit proper dental hygiene, though limiting the consumption of such foods and beverages surely will not hurt either. The center adds that regular dental checkups are crucial as well because skilled dentists are likely to spot potential ailments before they have a chance to develop into a painful and potentially very harmful condition which, unfortunately, can also occur among patients who take great care of their teeth.

A-Z Dental Care says that patients who do lose a tooth are not entirely out of luck. Dental implants can replace teeth that have been lost for any number of reasons. The clinic says that the process can be lengthy but, once it is complete, patients can enjoy the use of a tooth that looks and functions almost identically to their original tooth. Nevertheless, the clinic says that prevention should be the goal for all patients and stresses healthy choices along with routine checkups.

The dental center adds that while we can’t naturally replace our adult teeth, unlike dinosaurs people have plenty of options for prevention and dealing with dental ailments should they develop. A-Z Dental Care says that treatments such as root canals can rid a tooth of infection while preserving the vital root of a tooth. The center notes that it can perform surgical extractions as well as provide various medications for conditions such as chronic oral pain. It adds that all of these procedures can be performed while keeping patients comfortable with the involvement of an experienced and knowledgeable dentist.

Interested readers can learn more about A-Z Dental Ca re by visiting https://www.atozdentalcare.com/ or by calling (626) 314-6908.

Share article on social media or email:

Laura May Wehry’s newly released “The Purpose of Obedience” is a fundamental handbook that explains the importance of obedience


News Image

“The Purpose of Obedience”: a masterful book that will be seen as a journey by the readers, enabling them to know the truth and an honest humble opportunity to testify the goodness of God. “The Purpose of Obedience” is the creation of published author Laura May Wehry, a woman who came from a deeply devoted family of Christian women. She began her search to find the truth about thirty-five years ago. Many of her lessons of application the truth of the Bible were learned through the hard way of life.

Wehry writes, “This book was written to encourage the reader who has that specific question: ‘Why do I have to be obedient?’ In our world today, we have battled with this word obedience and have often believed that we are in a most vulnerable position by being obedient. I grew up in the sixties, believe me, I know the talk and walked that walk. I will make my way, thank you, and I do not need you to tell me different or so I thought; and I was already confused about what the man was saying about who I am to be.

“I pray that you have found that this was a lie then, and you also have questions about the why of obedience, and my greatest hope is that you have already begun this search for the answer as to why God says that he wants our obedience. Please read this small basic book that comes from my heart and the love that God has shared with me and accept that the purpose of obedience is the good news, and we are not more vulnerable but more than conquerors in this great journey of obedience. God blesses you.”

Published by Christian Faith Publishing, Laura May Wehry’s new book is an impelling craft that allows the readers to be enlightened and see the purpose of obeying God’s words and will.

With this book, Wehry hopes that readers may be able to find the answer as to why obeying God is important and the purpose of following His will.

View a synopsis of “The Purpose of Obedience” on YouTube.

Consumers can purchase “The Purpose of Obedience” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Purpose of Obedience,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Glaucoma, “The Sneak Thief of Sight,” Continues to Affect Vision of Millions of Americans


Prevent Blindness provides free resources to the public for January’s National Glaucoma Awareness Month

“The year 2020 is an ideal reminder for all of us to make the resolution today to save our vision for tomorrow,” said Jeff Todd, president and CEO of Prevent Blindness.

According to estimates from the Prevent Blindness report, “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems,” more than 3.2 million Americans ages 40 and over have glaucoma in the year 2020. The number is expected to increase as the population ages. Glaucoma, often referred to as the “The Sneak Thief of Sight,” is a leading cause of vision loss that damages the optic nerve. Although symptoms may not be noticeable at first, glaucoma slowly diminishes peripheral vision (side vision), making activities such as driving increasingly difficult.

January is National Glaucoma Awareness Month and Prevent Blindness, the nation’s oldest volunteer eye health and safety nonprofit organization, seeks to educate the public on the disease, including risk factors, types of glaucoma, treatment options and more. Prevent Blindness offers a dedicated web page providing patients and their caregivers with free information at https://www.preventblindness.org/glaucoma or its online resource, Living Well with Low Vision at https://lowvision.preventblindness.org.

More women than men have glaucoma. Risk factors for glaucoma also include:


  • Age- The older you are, the greater you are at risk (especially those more than 60 years old).
  • Race- African-Americans age 40 and over are 4-5 times more likely to have glaucoma than others. Hispanics are also at increased risk for glaucoma as they age. Those of Asian and Native American descent are at increased risk for angle closure glaucoma.
  • Family History- If you have a direct relative with glaucoma, you are more likely to get glaucoma. If you are diagnosed with glaucoma, strongly encourage your family members to get complete eye exams.
  • Medical History- You are at higher risk if you have a history of high pressure in the eyes, previous eye injury, long term steroid use, or are farsighted or nearsighted.

The American Academy of Ophthalmology (AAO) also states that those with diabetes, migraines, high blood pressure, poor blood circulation or other health problems affecting the whole body are at increased risk of glaucoma.

“The year 2020 is an ideal reminder for all of us to make the resolution today to save our vision for tomorrow,” said Jeff Todd, president and CEO of Prevent Blindness. “By detecting vision problems and treating them early, including those from glaucoma, we can help to avoid significant vision impairment.”

The AAO’s EyeCare America program provides eye care at no out-of-pocket cost to medically underserved seniors age 65 and older, and glaucoma exams to those at increased risk. For more information, visit https://www.aao.org/eyecare-america.

Allergan is supporting the efforts of Prevent Blindness in its public outreach efforts to protect vision from glaucoma. Allergan is a leading global pharmaceutical company with a more than 70-year heritage in eye care has launched over125 eye care products and invested billions of dollars in treatments for the most prevalent eye conditions including glaucoma, ocular surface disease, and retinal diseases such as diabetic macular edema and retinal vein occlusion. Recently, Allergan launched the My Glaucoma campaign which is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to feel comfortable speaking with their doctor about a treatment regimen that fits their lifestyle. For more information, visit http://www.MyGlaucoma.com.

For more information on glaucoma, or other financial assistance programs, including Medicare coverage, please call Prevent Blindness at (800) 331-2020 or visit https://www.preventblindness.org/glaucoma.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness.

Share article on social media or email:

Greenberg Traurig’s Henry Greenberg recognized on City & State’s ‘The Responsible 100’ List


Henry M. Greenberg, president of the New York State Bar Association (NYSBA) and a shareholder in the Albany office of global law firm Greenberg Traurig, LLP, was recognized by City & State with a spot on its 2019 “The Responsible 100” list. An awards ceremony recognizing honorees took place on Dec. 18 at Sony Hall in New York City. Featured speakers included Mary Stuart Masterson, founder of Stockade Works, and Rev. Al Sharpton, founder and president of the National Action Network.

According to City & State, “The Responsible 100” list honors New York’s most “outstanding responsible executives, thought leaders, visionaries and influencers who are setting new standards of excellence, dedication and leadership in improving their communities and making transformative change.”

Greenberg was active with the NYSBA for more than 20 years before becoming president in June 2019.

In addition, Greenberg serves on several professional committees and has leadership positions in other bodies. He is counsel to the New York State Commission on Judicial Nomination, which nominates New York’s Court of Appeals judges; chairs the Third Department Judicial Screening Committee and the New York State Fair Advisory Board; and is a member of the State Judicial Screening Committee, Judicial Task Force on the New York State Constitution, and the State Commission on the Restoration of the Capitol. He is also vice chair of statewide programming for The Historical Society of the New York Courts.

Greenberg concentrates his practice on civil litigation, criminal and civil investigations, health law matters, and regulatory and administrative law. He has previously served as counsel to New York State Attorney General (now Governor) Andrew M. Cuomo, counsel to the lieutenant governor of New York state, an assistant U.S. attorney (AUSA) for the Northern District of New York, and law clerk to then Associate Judge (later Chief Judge) Judith S. Kaye of the New York Court of Appeals.

About Greenberg Traurig

Greenberg Traurig, LLP (GT) has more than 2,100 attorneys in 41 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

Press Release News Wire Service